Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -28.58-29.41127.17-8.50468.50

What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?

The latest EBIT Growth ratio of BAFNA PHARMACEUTICALS is -28.58 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025-28.58
Mar2024-29.41
Mar2023127.17
Mar2022-8.50
Mar2021468.50

How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -28.58
Negative
Mar2024 -29.41
Negative
Mar2023 127.17
Positive
Mar2022 -8.5
Negative
Mar2021 468.5 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹288.8 Cr -0% -19.4% 45.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-0%

-19.4%

45.2%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses